Dublin, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/7b2w3s/sicklecell ) has announced the addition of the "Sickle-cell Anemia Therapeutics Market in the US 2015-2019" report to their offering. The Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period 2014-2019. This report covers the present scenario and the growth prospects of the Sickle-cell Anemia Therapeutics market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of the US FDA-approved drugs used for the treatment of sickle-cell anemia. It also covers the Sickle-cell Anemia Therapeutics market landscape in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Increasing focus on adult patients is one key trend in this market, which is anticipated to provide better healthcare services to adult patients and improve their QoL. According to the report, a high degree of unmet medical needs in terms of safe, efficacious, and epilepsy-modifying treatments is one of the major drivers of this market. Any drug that can cater to these demands is expected to drive the market during the forecast period of 2014-2019. . Further, the report states that the side effects associated with the current therapies are one of the major challenges faced by the market. The more side effects associated with a therapy, the lesser the compliance of patients, which consequently decreases the revenue generation of drugs in the market.
Key Vendors
- Bristol-Myers Squibb
Future Prominent Vendors
- Baxter
- Bluebird Bio
- Daiichi Sankyo
- Eli Lilly
- Emmaus Medical
- GlycoMimetics
- HemaQuest Pharmaceuticals
- Mast Therapeutics
- Merck Sharp & Dohme
- Pfizer
- Selexys Pharmaceuticals
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Disease Overview
- Introduction
- Market Landscape
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Future Prominent Vendors
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/7b2w3s/sicklecell
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices, Hematological
